反応式
[CH3:1][C:2]1[CH:8]=[C:7]([F:9])[CH:6]=[CH:5][C:3]=1[NH2:4].C(N(CC)CC)C.[CH3:17][O:18][CH2:19][C:20]1[N:25]=[C:24]([Cl:26])[N:23]=[C:22]([N:27]2[CH2:36][CH2:35][C:34]3[C:29](=[CH:30][CH:31]=[CH:32][CH:33]=3)[CH2:28]2)[C:21]=1[CH3:37]>CN(C)C=O>[ClH:26].[CH3:17][O:18][CH2:19][C:20]1[N:25]=[C:24]([NH:4][C:3]2[CH:5]=[CH:6][C:7]([F:9])=[CH:8][C:2]=2[CH3:1])[N:23]=[C:22]([N:27]2[CH2:36][CH2:35][C:34]3[C:29](=[CH:30][CH:31]=[CH:32][CH:33]=3)[CH2:28]2)[C:21]=1[CH3:37]参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
After 2-methyl-4-fluoroaniline(0.51 g, 4.5 mmol) and triethylamine (0.63 ml, 4.5 mmol) were added to a solution of 6-methoxymethyl-5-methyl-2-chloro-4-(1,2,3,4-tetrahydroisoquinolin-2-yl) pyrimidine(0.9 g, 3 mmol) in dimethylformamide (5 ml), 750 mg of the titled compound was obtained in accordance with the same procedure as in Step 2 of Example 25.
出典と根拠
- ORDレコード
- ord-4dd83efb903749b8b241e0ad758a2b9e
- 出典データセット
- uspto-grants-2002_03
- 特許番号
- US06352993B1
関連ノート
読み込み中…